ARKG vs SCHH
ARK Genomic Revolution ETF vs Schwab US REIT ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHH—
Schwab US REIT ETF
US REITs at very low cost.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHH |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHH top holdings
Holdings data unavailable for SCHH.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHH
SCHH (Schwab US REIT ETF) is US REITs at very low cost.